133 related articles for article (PubMed ID: 33359886)
21. Expression of long noncoding RNAs in breast cancer in relation to reproductive factors and tumor characteristics.
Ghafouri-Fard S; Taheri M; Omrani MD; Kholghi Oskooei V
J Cell Biochem; 2019 Aug; 120(8):13965-13973. PubMed ID: 30957286
[TBL] [Abstract][Full Text] [Related]
22. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer.
El-Ashmawy NE; Hussien FZ; El-Feky OA; Hamouda SM; Al-Ashmawy GM
Life Sci; 2020 Oct; 259():118193. PubMed ID: 32763293
[TBL] [Abstract][Full Text] [Related]
23. BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction.
Liu D; Zhou K
Clin Breast Cancer; 2020 Feb; 20(1):41-50.e8. PubMed ID: 31547956
[TBL] [Abstract][Full Text] [Related]
24. Assessment of SGO1 and SGO1-AS1 contribution in breast cancer.
Nasim N; Ghafouri-Fard S; Soleimani S; Esfandi F; Shirkhoda M; Safaei M; Oskooei VK; Taheri M; Raheb J
Hum Antibodies; 2019; 27(4):279-284. PubMed ID: 31156154
[TBL] [Abstract][Full Text] [Related]
25. Expression analysis of long non-coding ATB and its putative target in breast cancer.
Nikpayam E; Soudyab M; Tasharrofi B; Sarrafzadeh S; Iranpour M; Geranpayeh L; Mirfakhraie R; Gharesouran J; Ghafouri-Fard S
Breast Dis; 2017; 37(1):11-20. PubMed ID: 28598827
[TBL] [Abstract][Full Text] [Related]
26. Transcriptome Analysis Identifies GATA3-AS1 as a Long Noncoding RNA Associated with Resistance to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients.
Contreras-Espinosa L; Alcaraz N; De La Rosa-Velázquez IA; Díaz-Chávez J; Cabrera-Galeana P; Rebollar-Vega R; Reynoso-Noverón N; Maldonado-Martínez HA; González-Barrios R; Montiel-Manríquez R; Bautista-Sánchez D; Castro-Hernández C; Alvarez-Gomez RM; Jiménez-Trejo F; Tapia-Rodríguez M; García-Gordillo JA; Pérez-Rosas A; Bargallo-Rocha E; Arriaga-Canon C; Herrera LA
J Mol Diagn; 2021 Oct; 23(10):1306-1323. PubMed ID: 34358678
[TBL] [Abstract][Full Text] [Related]
27. A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer.
Tang Y; Wang Y; Wang X; Liu Y; Zheng K
Clin Breast Cancer; 2019 Jun; 19(3):e415-e421. PubMed ID: 30846409
[TBL] [Abstract][Full Text] [Related]
28. Expression Analysis of Long Non-Coding RNAs Related With FOXM1, GATA3, FOXA1 and ESR1 in Breast Tissues.
Hassani B; Taheri M; Asgari Y; Zekri A; Sattari A; Ghafouri-Fard S; Pouresmaeili F
Front Oncol; 2021; 11():671418. PubMed ID: 34094972
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA (lncRNA) DSCAM-AS1 is upregulated in breast cancer.
Tarighi M; Khalaj-Kondori M; Hosseinzadeh A; Abtin M
Breast Dis; 2021; 40(2):63-68. PubMed ID: 33554879
[TBL] [Abstract][Full Text] [Related]
30. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
[TBL] [Abstract][Full Text] [Related]
31. Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.
Wang R; Li Y; Du P; Zhang X; Li X; Cheng G
Life Sci; 2019 Sep; 233():116708. PubMed ID: 31369759
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of SLC16A-AS1 and LINC00900 lncRNAs in Iranian patients with breast cancer.
Dorostgoo Z; Fattahi AS; Moosavi SS; Ghafouri-Fard S; Oskooei VK
Breast Dis; 2022; 41(1):521-528. PubMed ID: 36641651
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological parameters.
Záveský L; Jandáková E; Weinberger V; Minář L; Kohoutová M; Slanař O
Cancer Biomark; 2024; 40(1):61-78. PubMed ID: 38277283
[TBL] [Abstract][Full Text] [Related]
34. Expression of cyclooxygenase-2 and 12-lipoxygenase in human breast cancer and their relationship with HER-2/neu and hormonal receptors: impact on prognosis and therapy.
Mohammad AM; Abdel HA; Abdel W; Ahmed AM; Wael T; Eiman G
Indian J Cancer; 2006; 43(4):163-8. PubMed ID: 17192687
[TBL] [Abstract][Full Text] [Related]
35. Down-regulated lncRNA SLC25A5-AS1 facilitates cell growth and inhibits apoptosis via miR-19a-3p/PTEN/PI3K/AKT signalling pathway in gastric cancer.
Li X; Yan X; Wang F; Yang Q; Luo X; Kong J; Ju S
J Cell Mol Med; 2019 Apr; 23(4):2920-2932. PubMed ID: 30793479
[TBL] [Abstract][Full Text] [Related]
36. Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.
Li Y; Zhang X; Qiu J; Pang T; Huang L; Zeng Q
J BUON; 2019; 24(6):2361-2368. PubMed ID: 31983107
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of long noncoding RNA TP73-AS1 suppresses the malignant progression of breast cancer cells in vitro through targeting miRNA-125a-3p/metadherin axis.
Liu Y; Wei G; Ma Q; Han Y
Thorac Cancer; 2020 Feb; 11(2):394-407. PubMed ID: 31901156
[TBL] [Abstract][Full Text] [Related]
38. In silico identification of MAPK14-related lncRNAs and assessment of their expression in breast cancer samples.
Dashti S; Taherian-Esfahani Z; Kholghi-Oskooei V; Noroozi R; Arsang-Jang S; Ghafouri-Fard S; Taheri M
Sci Rep; 2020 May; 10(1):8316. PubMed ID: 32433496
[TBL] [Abstract][Full Text] [Related]
39. ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer.
Ma B; Ma Q; Jin C; Wang X; Zhang G; Zhang H; Seeger H; Mueck AO
Int J Clin Exp Pathol; 2015; 8(10):13279-83. PubMed ID: 26722530
[TBL] [Abstract][Full Text] [Related]
40. Identification of Long Noncoding RNAs as Predictors of Survival in Triple-Negative Breast Cancer Based on Network Analysis.
Li XX; Wang LJ; Hou J; Liu HY; Wang R; Wang C; Xie WH
Biomed Res Int; 2020; 2020():8970340. PubMed ID: 32190687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]